Clinical Trial Update: Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the immunogenicity and safety of three meningococcal B vaccine strategies in patients with asplenia, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asplenia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Splenectomy | Phase 3 | Status: RECRUITING